Muscular dystrophy, which affects approximately 250,000 people in the U.S., occurs when damaged muscle tissue is replaced with fibrous, fatty or bony tissue and loses function. For years, scientists have searched for a way to successfully treat the most common form of the disease, Duchenne Muscular Dystrophy (DMD), which primarily affects boys. Now, a team of University of Missouri researchers have successfully treated dogs with DMD and say that human clinical trials are being planned in the next few years.
“This is the most common muscle disease in boys, and there is currently no effective therapy,” saidDongsheng Duan, the study leader and the Margaret Proctor Mulligan Professor in Medical Research at the MU School of Medicine. “This discovery took our research team more than 10 years, but we believe we are on the cusp of having a treatment for the disease.”
Patients with Duchenne muscular dystrophy have a gene mutation that disrupts the production of a protein known as “dystrophin.” Absence of dystrophin starts a chain reaction that eventually leads to muscle cell degeneration and death. Affected boys lose their ability to walk and breathe as they get older. This places significant limitations on individuals afflicted with the disease. Dystrophin also is one of the largest genes in the human body.
“Due to its size, it is impossible to deliver the entire gene with a gene therapy vector, which is the vehicle that carries the therapeutic gene to the correct site in the body,” Duan said. “Through previous research, we were able to develop a miniature version of this gene called a microgene. This minimized dystrophin protected all muscles in the body of diseased mice.”
However, it took the team more than 10 years to develop a strategy that can safely send the micro-dystrophin to every muscle in a dog that is afflicted by the disease. The dog has a body size similar to that of an affected boy. Success in the dog will set the foundation for human tests.
In this latest study, the MU team demonstrated for the first time that a common virus can deliver the microgene to all muscles in the body of a diseased dog. The dogs were injected with the virus when they were two to three months old and just starting to show signs of DMD. The dogs are now six to seven months old and continue to develop normally.
“The virus we are using is one of the most common viruses; it is also a virus that produces no symptoms in the human body, making this a safe way to spread the dystrophin gene throughout the body,” Duan said. “These dogs develop DMD naturally in a similar manner as humans. It’s important to treat DMD early before the disease does a lot of damage as this therapy has the greatest impact at the early stages in life.”
The Latest on: Muscular Dystrophy
[google_news title=”” keyword=”Muscular Dystrophy” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Muscular Dystrophy
- Midland Fire Fighters host the Annual Fill the Boot campaignon April 26, 2024 at 11:23 pm
that’s because MFD kicked off its annual fill the Boot campaign. Midland firefighters and volunteers are walking along the streets to fundraise money and their goal is to fill up this boot to help the ...
- These 15 One-of-a-Kind Watches Won’t Appear at the OnlyWatch Auction. We Asked the Brands Why.on April 26, 2024 at 9:00 am
We asked 15 brands why their unique timepieces for OnlyWatch will not appear at the rescheduled auction in Geneva next month, and what the fate of those watches might be.
- Patients With DMD Receiving Eteplirsen Show Prolonged Survival, Study Findson April 25, 2024 at 2:03 pm
The study provides evidence of survival benefits among patients with Duchenne muscular dystrophy (DMD) receiving eteplirsen compared with the natural history of the condition.
- Muscular Dystrophy UK Earns PIF TICK Accreditationon April 25, 2024 at 7:48 am
Muscular Dystrophy UK, the leading charity for more than 110,000 children and adults in the UK living with one of over 60 muscle wasting and weakening ...
- DeWine: Ohio first state in the nation to screen newborn babies for Duchenne Muscular Dystrophyon April 24, 2024 at 9:00 pm
Ohio Gov. Mike DeWine on Monday announced that Ohio will become the first state in the nation to begin screening all newborn babies for Duchenne Muscular Dystrophy. The provision was included in HR 33 ...
- Researchers uncover SNUPN gene responsible for a new muscular disorderon April 24, 2024 at 8:03 am
A study, published in Nature Communications, sheds light on a newly identified subtype of muscular dystrophy, revealing an unsuspected role of SNUPN gene in muscle cell function.
- Gov. DeWine announces Ohio will be first state to screen newborns for DMDon April 24, 2024 at 7:23 am
Gov. Mike DeWine announced Tuesday that the state of Ohio will become the first in the United States to screen all newborn babies for Duchenne muscular dystrophy.
- Ohio sets the trend in screening newborns for rare disease. What to know about DMDon April 24, 2024 at 3:58 am
Ohio Gov. Mike DeWine announced the state will be the first in the nation to screen newborns for the rare disease Duchenne Muscular Dystrophy.
- Edgewise gets EU orphan drug status for muscular dystrophy drugon April 23, 2024 at 7:29 am
Edgewise Therapeutics (EWTX) has received orphan drug designation from EU regulators for sevasemten in the treatment of Becker and Duchenne muscular dystrophies. Read more here.
- Duchenne UK and Parent Project Muscular Dystrophy Award $500,000 to Evaluate Safety and Tolerability of Muscle Progenitor Cells in Phase 1 Trialon April 23, 2024 at 7:01 am
Parent Project Muscular Dystrophy (PPMD), a US nonprofit organization, and the UK charity Duchenne UK, two leading organizations dedicated to ending Duchenne muscular dystrophy (Duchenne), are excited ...
via Bing News